Return to homepagePandemic Pact

NAVIX (NAsal VaccInation against pathogen X

  • Funded by Institut Pasteur International Network (IPIN)
  • Total publications:0 publications

Grant number: 270254

Grant search

Key facts

  • Disease

    Disease X

  • Start & end year

    2026

  • Known Financial Commitments (USD)

    $0

  • Funder

    Institut Pasteur International Network (IPIN)

  • Principal Investigator

    James Di Santo

  • Research Location

    99

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

NAVIX (NAsal VaccInation against pathogen X) is a France Vaccins-funded project within the framework of France 2030. It is coordinated by the Institut Pasteur de Lille, dedicated to the development of next-generation intranasal vaccine platforms against pathogens of pandemic concern. The project focuses on the rational design of innovative mucosal vaccine components, including targeted antigens, mucosal adjuvants, and advanced delivery systems based on nanoparticle formulations and viral vectors. These candidate vaccines will be evaluated through comprehensive preclinical studies using advanced in vitro and animal models to rigorously assess their immunogenicity and protective efficacy.